Riskpilot← Back to searchSign inGet full accessMedipulssi Oy
OYActiveY-tunnus 2769063-8Pekanraitti 15General medical practice activities · NACE 8621Est. 2016— employeeswww.medipulssi.fi
Revenue 2024
EUR 814K
-5% vs 2023
EBITDA margin
-51.9%
-55% vs 2023
Equity ratio
89.1%
Financial strength
Net profit 2024
EUR -229K
-127% vs 2023
| Revenue | EUR 814K | -5% |
| EBITDA | EUR -422K | -55% |
| Net profit | EUR -229K | -127% |
| Total assets | EUR 4,4M | -6% |
| Equity | EUR 4M | -4% |
| Employees | — | — |
Legal name
Medipulssi Oy
Y-tunnus number
2769063-8
Legal form
Osakeyhtiö
NACE code
8621 · General medical practice activities
Founded
22. kesäkuuta 2016
Share capital
EUR 2 502
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Vuokratyövoiman välitys. Terveydenhuollon palvelujen tuottaminen.
Address
Pekanraitti 15
Phone
+3580407708006
Email
info@medipulssi.fi
Website
www.medipulssi.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 276 | 6 158 | 4 049 | 859 | 814 |
| Staff expenses | −1 792 | −2 445 | −2 161 | −678 | −619 |
| EBITDA | 633 | 1 078 | 1 420 | −272 | −422 |
| Depreciation & amort. | −12 | −31 | −56 | −42 | −33 |
| EBIT | 621 | 1 047 | 1 364 | −314 | −455 |
| Net financials | — | 212 | 621 | 1 213 | 227 |
| Profit before tax | 621 | 1 259 | 1 985 | 899 | −228 |
| Tax | 94 | 215 | 275 | 56 | 1 |
| Net profit | 527 | 1 044 | 1 711 | 844 | −229 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 709 | 2 771 | 4 456 | 4 721 | 4 434 |
| Equity | 1 398 | 2 248 | 3 559 | 4 118 | 3 950 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 311 | 523 | 897 | 602 | 484 |
| Total debt | 311 | 523 | 897 | 602 | 484 |
EBITDA margin
-51.9%
This company
15.8%
Market median
-428% vs market
20202024
Equity ratio
89.1%
This company
38.2%
Market median
+133% vs market
20202024
Return on equity
-5.8%
This company
18.4%
Market median
-132% vs market
20202024
Net profit margin
-28.2%
This company
8.1%
Market median
-448% vs market
20202024
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20202024
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MH Chief Executive Officer | Chief Executive Officer | 2018 |
| Former (3) | ||
MJ | Audit | 2020 – 2023 |
SS Confidential Clerk | Confidential Clerk | 2020 – 2024 |
AS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2018 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2024 | |
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medipulssi Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohamud Hussein Mohamed | Chief Executive Officer | 0 companies |
| Matti Johannes Koskelainen | Audit | 0 companies |
| Serdar Simsek | Confidential Clerk | 0 companies |
| Abdulsamet Simsek | Deputy Chief Executive Officer | 0 companies |
| Hunderra Assefa | Chairperson | 0 companies |
| Mohamed Yahya | Board of Directors | 0 companies |